Nebius Customer AtlasNot affiliated · Research by Not affiliated · By @anthonybs
Not affiliated with Nebius · Independent research by @anthonybsSee changes
AllMultiply Labs

Multiply Labs

Builds robotic systems for biologics…

How they use Nebius AI Cloud

Multiply Labs uses Nebius H100 GPUs for training as part of its robotics R&D for biologics manufacturing. Its team added Nebius and GCP after expanding beyond its initial AWS region to improve access to premium GPUs.

Through Anyscale, the team deploys managed Ray clusters across clouds using infrastructure-as-code pipelines. Anyscale reports that this automation reduced startup time for Nebius H100 training clusters from 30 to 10 minutes. Multiply Labs engineer Varun Bhatia also describes a portable training environment that lets the team follow available GPU capacity across AWS, GCP and Nebius.

HealthService: Nebius AI CloudTraining & fine-tuning

Sources

2 sources

Multiply Labs Advances AI for Biologics Robotics on Anyscale

Listed 20 Oct 2026 · Anyscale · Web page

Anyscale describes Multiply Labs adding Nebius for GPU access and using Nebius H100 clusters for training. It reports that deployment automation reduced startup time for those clusters from 30 to 10 minutes.

Open original source
Multiply Labs Advances AI for Biologics Robotics on AnyscaleListed 20 Oct 2026 · Anyscale · Web pageAnyscale describes Multiply Labs adding Nebius for GPU access and using Nebius H100 clusters for training. It reports that deployment automation reduced startup time for those clusters from 30 to 10 minutes.

Varun Bhatia on Multiply Labs’ multi-cloud training infrastructure

Listed 20 Oct 2026 · LinkedIn · Web page

Multiply Labs engineer Varun Bhatia describes infrastructure-as-code pipelines for deployment across AWS, GCP and Nebius. He says its portable Anyscale Ray environment reduced the time needed to start training software.

Open original source
Varun Bhatia on Multiply Labs’ multi-cloud training infrastructureListed 20 Oct 2026 · LinkedIn · Web pageMultiply Labs engineer Varun Bhatia describes infrastructure-as-code pipelines for deployment across AWS, GCP and Nebius. He says its portable Anyscale Ray environment reduced the time needed to start training software.

Company context

multiplylabs.com

Multiply Labs, operated by Multiply Labs, Inc., builds robotic systems that automate biologic drug manufacturing for pharmaceutical and biotechnology companies. Its modular robotic clusters connect existing manufacturing instruments and automate repetitive steps within enclosed environments. Control software executes manufacturing protocols, monitors sensors and supplies electronic records to customers’ quality systems. Manufacturers own and operate the equipment in their own facilities. Initially focused on cell and gene therapies, the platform is expanding into antibodies, viral vectors and mRNA manufacturing.

Documented financing · private company

Amount$75 millionSeries B
· Multiply Labs

Recent updates

1 update

  1. Funding

    Multiply Labs raises $75 million Series B

    Multiply Labs announced a $75 million Series B led by Patrick Soon-Shiong with NantWorks, bringing total capital raised above $100 million. The company will expand manufacturing capacity, accelerate product development and grow its engineering, regulatory and commercial teams.

    Multiply Labs
Next, A–ZNathan & Brank
← Explore all customers

Multiply Labs

Multiply Labs builds robotic systems for biologics manufacturing. · Health

How they use Nebius AI Cloud

Multiply Labs uses Nebius H100 GPUs for training as part of its robotics R&D for biologics manufacturing. Its team added Nebius and GCP after expanding beyond its initial AWS region to improve access to premium GPUs.

Through Anyscale, the team deploys managed Ray clusters across clouds using infrastructure-as-code pipelines. Anyscale reports that this automation reduced startup time for Nebius H100 training clusters from 30 to 10 minutes. Multiply Labs engineer Varun Bhatia also describes a portable training environment that lets the team follow available GPU capacity across AWS, GCP and Nebius.

HealthService: Nebius AI CloudTraining & fine-tuning

Sources

2 sources

Multiply Labs Advances AI for Biologics Robotics on Anyscale

Listed 20 Oct 2026 · Anyscale · Web page

Anyscale describes Multiply Labs adding Nebius for GPU access and using Nebius H100 clusters for training. It reports that deployment automation reduced startup time for those clusters from 30 to 10 minutes.

Open original source
Multiply Labs Advances AI for Biologics Robotics on AnyscaleListed 20 Oct 2026 · Anyscale · Web pageAnyscale describes Multiply Labs adding Nebius for GPU access and using Nebius H100 clusters for training. It reports that deployment automation reduced startup time for those clusters from 30 to 10 minutes.

Varun Bhatia on Multiply Labs’ multi-cloud training infrastructure

Listed 20 Oct 2026 · LinkedIn · Web page

Multiply Labs engineer Varun Bhatia describes infrastructure-as-code pipelines for deployment across AWS, GCP and Nebius. He says its portable Anyscale Ray environment reduced the time needed to start training software.

Open original source
Varun Bhatia on Multiply Labs’ multi-cloud training infrastructureListed 20 Oct 2026 · LinkedIn · Web pageMultiply Labs engineer Varun Bhatia describes infrastructure-as-code pipelines for deployment across AWS, GCP and Nebius. He says its portable Anyscale Ray environment reduced the time needed to start training software.

Company context

multiplylabs.com

Multiply Labs, operated by Multiply Labs, Inc., builds robotic systems that automate biologic drug manufacturing for pharmaceutical and biotechnology companies. Its modular robotic clusters connect existing manufacturing instruments and automate repetitive steps within enclosed environments. Control software executes manufacturing protocols, monitors sensors and supplies electronic records to customers’ quality systems. Manufacturers own and operate the equipment in their own facilities. Initially focused on cell and gene therapies, the platform is expanding into antibodies, viral vectors and mRNA manufacturing.

Documented financing · private company

Amount$75 millionSeries B
· Multiply Labs

Recent updates

1 update

  1. Funding

    Multiply Labs raises $75 million Series B

    Multiply Labs announced a $75 million Series B led by Patrick Soon-Shiong with NantWorks, bringing total capital raised above $100 million. The company will expand manufacturing capacity, accelerate product development and grow its engineering, regulatory and commercial teams.

    Multiply Labs

More in Health

AikiumAnemos BioAtaraxis AI